# Prexton Therapeutics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/prexton-therapeutics

- Industry: Pharmaceuticals
- Headquarters: Netherlands
- Website: www.prextontherapeutics.com
- Total disclosed funding: $43M
- Latest round: Series B (Feb 7, 2017)
- Investors on record: 5

## About

Founded in 2012 and based in Geneva, Switzerland, Prexton Therapeutics SA develops drugs for treatment of Parkinson’s disease and other central nervous system disorders.

## Funding rounds

- Series B, Feb 7, 2017, $31M — Seroba, Forbion, Heartcore Capital, Ysios Capital Partners, M Ventures
- Series A, Feb 24, 2015, $9.9M — Heartcore Capital, Ysios Capital Partners, M Ventures
- Seed, Jul 30, 2012, $2.6M — M Ventures

## Investors

- M Ventures (https://capitalatlas.ai/funds/m-ventures) — Seed, Series A, Series B
- Heartcore Capital (https://capitalatlas.ai/funds/heartcore-capital) — Series A, Series B
- Ysios Capital Partners (https://capitalatlas.ai/funds/ysios-capital-partners) — Series A, Series B
- Seroba (https://capitalatlas.ai/funds/seroba) — Series B
- Forbion (https://capitalatlas.ai/funds/forbion) — Series B